← SynDRA
ULIXERTINIB
SynDRA canonical compound SYN0038328 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | MAP kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MAPK3 INHIBITOR
- MAP kinase ERK1 inhibitor
- MAPK1 INHIBITOR
- MAP kinase ERK2 inhibitor
- MEK inhibitor
Cross-references
Synonyms
- BVD-523
- BVD-ERK
- ULIXERTINIB (BVD-523)
- VRT-752271
- VRT752271
- ulixertinibum
- RefChem:192996
- Ulixertinib [INN]
- Ulixertinib (BVD-523)
- UNII-16ZDH50O1U
- Ulixertinib (BVD-523, VRT752271)
- Ulixertinib (INN)
- MFCD22543853
- MFCD22628898
- Ulixertinib (BVD-523,VRT752271)
- BVD523 HCl
- BVD-523 HCl
- ULIXERTINIB [WHO-DD]
- GTPL9210
- orb1300149
- SCHEMBL14211742
- SCHEMBL29456946
- SCHEMBL29712842
- GLXC-90461
- EX-A1332
- BDBM50094465
- NSC797771
- NSC800959
- s7854
- AKOS025396467
- CCG-269049
- EBC-218036
- NSC-797771
- NSC-800959
- NCGC00378692-02
- NCGC00378692-04
- NCGC00378692-05
- NCGC00378692-07
- AC-33165
Look up ULIXERTINIB in the interactive SynDRA portal →